International

EU to discuss U.S. vaccine patent plan

Demonstrators hold a rally to "Free the Vaccine," calling on the U.S. to commit to a global coronavirus vaccination plan that includes sharing vaccine formulas with the world to help ensure that every nation has access to a vaccine, on the National Mall in Washington, DC, May 5, 2021.   | Photo Credit: AFP

France joined the United States on Thursday in supporting an easing of patent and other protections on COVID-19 vaccines that could help poorer countries get more doses and speed the end of the pandemic.

The move to support waiving intellectual property protections on vaccines under World Trade Organization rules marked a dramatic shift for the United States — and drew cheers from activists, complaints from Big Pharma, and a lot of questions about what comes next. Washington had previously lined up with many other developed nations opposed to the idea floated by India and South Africa in October.

Explained | What the easing of IP norms on Covid vaccines means for India

Attention is now turning to those richer nations, notably in the European Union — and France was the first to voice its support.

“I completely favour this opening up of the intellectual property,” French President Emmanuel Macron said Thursday on a visit to a vaccine centre.

The EU Commission President, Ursula von der Leyen, said the 27-nation bloc was ready to talk about the U.S. proposal — but cagily remained non-committal for now.

 

“We are ready to discuss how the U.S. proposal for waiver could help” end the crisis, she said in a video address. “In the short run, however, we call upon all vaccine producing countries to allow exports and to avoid measures that disrupt supply chains.”

Russian President Vladimir Putin also said he supported the idea of a waiver on patent protections for coronavirus vaccines.


Our code of editorial values

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Jun 19, 2021 3:51:00 PM | https://www.thehindu.com/news/international/eu-to-discuss-us-vaccine-patent-plan/article34500378.ece

Next Story